The mission of the American Society for Hematology, the world's largest professional organization dedicated to the causes and treatment of blood disorders, is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems through support for research, clinical care, education, training, and advocacy.
To that end, ASH is accepting proposals from hematologists whose research would not otherwise be accomplished due to cuts in funding from the National Institutes of Health. Established in January 2013, the long-term goal of the program is to help sustain recipients’ research and keep them engaged in hematology investigation.
The Bridge Grants program will provide at least thirty one-year awards annually, in the amount of $150,000 each, to ASH members who applied for an NIH R01 grant or equivalent but were denied funding due to budget cuts. Grants support projects in basic, translational, patient-oriented, and outcomes-based research.
To be eligible, applicants must hold a faculty position in an academic institution or the equivalent position in a nonprofit research organization and have submitted a hematology-related R01 or equivalent application to NIH in the past eighteen months that was scored but not funded. ASH membership is required at the time of application and throughout the award period.
See the ASH website for complete program guidelines and application procedures.